Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pediatric use of prescribed melatonin in Sweden 2006–2017: a register based study
Elin Kimland, Carola Bardage, Julius Collin, et al.
European Child & Adolescent Psychiatry (2020) Vol. 30, Iss. 9, pp. 1339-1350
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Melatonin use in typically developing (TD) children: International Pediatric Sleep Association (IPSA) Expert Consensus Recommendations for Healthcare Providers
Judith Owens, Narong Simakajornboon, Suresh Kotagal, et al.
Sleep Medicine (2025) Vol. 128, pp. 127-129
Closed Access | Times Cited: 2
Safety of higher doses of melatonin in adults: A systematic review and meta‐analysis
Zoe Menczel Schrire, Craig L. Phillips, Julia L. Chapman, et al.
Journal of Pineal Research (2021) Vol. 72, Iss. 2
Open Access | Times Cited: 82
Melatonin Use in Managing Insomnia in Typically Developing (TD) Children: A Technical Report
Judith Owens, Narong Simakajornboon, Suresh Kotagal, et al.
Sleep Medicine (2025)
Closed Access | Times Cited: 1
Chronic Administration of Melatonin: Physiological and Clinical Considerations
Donald Givler, Amy Givler, Patrick M. Luther, et al.
Neurology International (2023) Vol. 15, Iss. 1, pp. 518-533
Open Access | Times Cited: 21
Sleep interventions for children with attention deficit hyperactivity disorder (ADHD): A systematic literature review
Ingrid Larsson, Katarina Aili, Maria Lönn, et al.
Sleep Medicine (2022) Vol. 102, pp. 64-75
Open Access | Times Cited: 26
Melatonin: A Potential Candidate for the Treatment of Experimental and Clinical Perinatal Asphyxia
Ryszard Pluta, Wanda Furmaga-Jabłońska, Sławomir Januszewski, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1105-1105
Open Access | Times Cited: 13
Melatonin use among children, adolescents, and young adults: a Danish nationwide drug utilization study
Mette Bliddal, Helene Kildegaard, Lotte Rasmussen, et al.
European Child & Adolescent Psychiatry (2022) Vol. 32, Iss. 10, pp. 2021-2029
Closed Access | Times Cited: 17
Prescription Trends of Medications Used to Treat Sleep Disturbances in School-aged Children: An Interrupted Time-Series Analysis in France, 2016-2023
Zaba Valtuille, Éric Acquaviva, Vincent Trebossen, et al.
The Journal of Pediatrics (2025), pp. 114502-114502
Open Access
What do we really know about the safety and efficacy of melatonin for sleep disorders?
David J. Kennaway
Current Medical Research and Opinion (2021) Vol. 38, Iss. 2, pp. 211-227
Closed Access | Times Cited: 22
Melatonin usage in children and young adults, a registry-based cohort study
Kristina Tedroff, Mia von Euler, Elin Dahlén
European Journal of Paediatric Neurology (2022) Vol. 39, pp. 30-34
Open Access | Times Cited: 14
Melatonin use in children and adolescents: A scoping review of caregiver perspectives
Samantha K. M. Lee, Lorraine Smith, Edwin C.K. Tan, et al.
Sleep Medicine Reviews (2023) Vol. 70, pp. 101808-101808
Closed Access | Times Cited: 8
Melatonin Supplementation in Undetermined Pediatric Deaths
Sandra C Bishop-Freeman, Kerry Young, Laura M. Labay, et al.
Journal of Analytical Toxicology (2022) Vol. 46, Iss. 8, pp. 808-816
Closed Access | Times Cited: 12
New users of anxiolytics and sedatives in Sweden—Drug type, doses, prescribers' characteristics, and psychiatric comorbidity in more than 750,000 patients
Elin Dahlén, Carola Bardage, Paulina Tuvendal, et al.
International Journal of Methods in Psychiatric Research (2024) Vol. 33, Iss. 1
Open Access | Times Cited: 2
Considerable paediatric drug dispensing – A nationwide study of more than 2 million Swedish children
Elin Dahlén, Elin Kimland
Acta Paediatrica (2024) Vol. 113, Iss. 9, pp. 2147-2154
Open Access | Times Cited: 2
Factors associated with melatonin use in child sleep disturbance: A survey of Australian parents
Alison Glass, Ceinwyn Attrill, Chris Magee, et al.
Sleep Medicine (2023) Vol. 107, pp. 330-337
Closed Access | Times Cited: 6
Using pharmacotherapy to address sleep disturbances in autism spectrum disorders
Valeria Mammarella, Silvia Orecchio, Noemi Cameli, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 12, pp. 1261-1276
Closed Access | Times Cited: 6
Melatonin Treatment for Pediatric Patients with Insomnia: Is There a Place for It?
Julie Rolling, Juliette Rabot, Carmen Schröder
Nature and Science of Sleep (2022) Vol. Volume 14, pp. 1927-1944
Open Access | Times Cited: 10
Adverse events in long-term studies of exogenous melatonin
Frank Besag, Michael J. Vasey
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 12, pp. 1469-1481
Closed Access | Times Cited: 9
Melatonin use and the risk of self‐harm and unintentional injuries in youths with and without psychiatric disorders
Marica Leone, Ralf Kuja‐Halkola, Tyra Lagerberg, et al.
Journal of Child Psychology and Psychiatry (2023) Vol. 64, Iss. 7, pp. 1027-1036
Open Access | Times Cited: 5
Melatonin Prescription in Children and Adolescents in Relation to Body Weight and Age
Elin Kimland, Elin Dahlén, Jari Martikainen, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 396-396
Open Access | Times Cited: 4
Associations between treatment with melatonin and suicidal behavior: a nationwide cohort study
Nikolaj Kjær Høier, Trine Madsen, Adam P. Spira, et al.
Journal of Clinical Sleep Medicine (2022) Vol. 18, Iss. 10, pp. 2451-2458
Open Access | Times Cited: 7
Psychotropic use in children and adolescents in Scandinavia and Catalonia: a 10-year population-based study
Ainhoa Gómez-Lumbreras, Ana García-Sangenís, Oriol Prat Vallverdú, et al.
Psychopharmacology (2021) Vol. 238, Iss. 7, pp. 1805-1815
Open Access | Times Cited: 9
Melatonin dispensing among New Zealand children aged 0–18 years with autism: a nationwide cross-sectional study
Laurie McLay, Philip J. Schlüter, Matthew Eggleston, et al.
Sleep Medicine (2021) Vol. 80, pp. 184-192
Closed Access | Times Cited: 8
Trends, geographical variation and factors associated with melatonin prescribing in general practices in England: A practice‐level analysis
Mandy Wan, Rukeya Begum, Asia N Rashed
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 5, pp. 2430-2436
Open Access | Times Cited: 8
Melatonin dispensing and polypharmacy rates for New Zealand children with autism or attention deficit hyperactivity disorders: A nationwide pharmacoepidemiological study
Laurie McLay, Nicholas Bowden, Matthew Eggleston, et al.
Research in autism spectrum disorders (2022) Vol. 93, pp. 101948-101948
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top